Abstract
Phage display technology utilises peptide and antibody libraries with very high diversities to select ligands with specific binding properties. The production of such libraries can be labour intensive and technically challenging and whilst there are commercial sources of libraries, the exploitation of the resulting binders is constrained by ownership of the libraries. Here, a peptide library of ~ 1 × 109 variants for display on gene VIII was produced alongside three VHH antibody libraries with similar diversity, where 12mer, 16mer or 21mer CDR3s were introduced into the highly stable cAbBCII10 scaffold displayed on gene III. The cloning strategy used a simple whole-plasmid PCR method and type IIS restriction enzyme assembly that facilitate the seamless insertion of diversity into any suitable phage coat protein or antibody scaffold. This method reproducibly produced 1 × 109 variants from just 10 transformations and the four libraries had relatively low bias with 82 to 86% of all sequences present as single copies. The functionality of both peptide and antibody libraries were demonstrated by selection of ligands with specific binding properties by biopanning. The peptide library was used to epitope map a monoclonal antibody. The VHH libraries were pooled and used to select an antibody to recombinant human collagen type 1.
Highlights
Phage display technology was first described in 1985 by George Smith [1] and has been developed to include the display of peptides, various recombinant antibody formats, enzymes and fragmented proteomes [2,3,4]
One 16mer peptide library displayed on pVIII and three VHH libraries displayed on pIII protein
The latter were based on a single scaffold (CAbBII10) with diversity introduced by the insertion of random peptides of 12, 16 and 21 amino acids in length within the CDR3 site
Summary
Phage display technology was first described in 1985 by George Smith [1] and has been developed to include the display of peptides, various recombinant antibody formats, enzymes and fragmented proteomes [2,3,4]. These phage libraries can display vast diversities of ligands on coat proteins projecting from the surface of the bacteriophage particle, utilising either a phagemid or phage vector system to encode the ligand-coat protein fusion [5,6,7]. It may be required to produce bespoke synthetic onepot ligand libraries containing a high diversity of potential binders that can provide antibodies or peptides to any target antigen with no constraints on use
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.